Data / Drug companies / Dopamine hydrochloride
Dopamine hydrochloride: 10 companies and 23 products in the FDA NDC directory
Dopamine hydrochloride is listed in the FDA National Drug Code Directory by 10 companies, with 23 products in commercial distribution. 8 of the products (34.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection; injection, solution, concentrate; injection, solution, and the newest product started marketing on February 18, 2022.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 23
- Generic (ANDA) products
- 8 (34.8%)
- Application numbers
- 4
- Routes
- Intravenous, Oral
- Brand names
- Dopamine, Dopamine Phenolic
- openFDA record search
- api.fda.gov
Companies that list dopamine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | 4 | injection | Generic drugs (ANDA) | April 11, 2018 |
| Baxter Healthcare Corporation | 3 | injection, solution | New drug applications (NDA) | March 27, 1987 |
| HF Acquisition Co LLC, DBA HealthFirst | 3 | injection; injection, solution | Generic drugs (ANDA) | August 7, 2021 |
| ProPharma Distribution | 3 | injection, solution, concentrate; injection, solution | New drug applications (NDA) | April 11, 2018 |
| BioActive Nutritional, Inc. | 2 | liquid | Unapproved homeopathic products | August 16, 2016 |
| Henry Schein, Inc. | 2 | injection, solution, concentrate | New drug applications (NDA) | February 18, 2022 |
| Hospira, Inc. | 2 | injection, solution, concentrate | New drug applications (NDA) | August 25, 2005 |
| Medical Purchasing Solutions, LLC | 2 | injection; injection, solution, concentrate | Generic drugs (ANDA) | April 11, 2018 |
| Deseret Biologicals, Inc. | 1 | liquid | Unapproved homeopathic products | July 27, 2018 |
| Energique, Inc. | 1 | liquid | Unapproved homeopathic products | July 14, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 8 | 34.8% |
| Injection, solution, concentrate | 6 | 26.1% |
| Injection, solution | 5 | 21.7% |
| Liquid | 4 | 17.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 11 | 47.8% |
| Generic drugs (ANDA) | 8 | 34.8% |
| Unapproved homeopathic products | 4 | 17.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Catecholamine | 23 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.